Suntrust Banks’s AbbVie ABBV Stock Holding History

Suntrust Banks’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$80.9M	Buy	1,067,953 +41,544	+4%	+$2.85M	0.42%	54
2019 Q2	$74.6M	Sell	1,026,409 -21,329	-2%	-$1.68M	0.39%	56
2019 Q1	$84.4M	Buy	1,047,738 +62,704	+6%	+$5.13M	0.44%	46
2018 Q4	$90.8M	Buy	985,034 +34,775	+4%	+$3.06M	0.52%	38
2018 Q3	$89.9M	Buy	950,259 +44,780	+5%	+$4.25M	0.46%	44
2018 Q2	$83.9M	Buy	905,479 +16,614	+2%	+$1.62M	0.46%	45
2018 Q1	$84.1M	Sell	888,865 -20,952	-2%	-$2.3M	0.47%	42
2017 Q4	$88M	Sell	909,817 -16,156	-2%	-$1.52M	0.51%	39
2017 Q3	$82.3M	Sell	925,973 -64,600	-7%	-$4.92M	0.49%	38
2017 Q2	$71.8M	Sell	990,573 -7,235	-0.7%	-$486K	0.44%	48
2017 Q1	$65M	Sell	997,808 -175,059	-15%	-$11M	0.41%	50
2016 Q4	$73.4M	Sell	1,172,867 -27,622	-2%	-$1.69M	0.44%	48
2016 Q3	$75.7M	Buy	1,200,489 +94,219	+9%	+$6.1M	0.47%	46
2016 Q2	$68.5M	Buy	1,106,270 +3,473	+0.3%	+$212K	0.42%	48
2016 Q1	$63M	Buy	1,102,797 +206,994	+23%	+$11.5M	0.39%	51
2015 Q4	$53.1M	Sell	895,803 -18,350	-2%	-$1.06M	0.33%	58
2015 Q3	$49.7M	Sell	914,153 -19,010	-2%	-$1.24M	0.34%	61
2015 Q2	$62.7M	Sell	933,163 -19,077	-2%	-$1.25M	0.4%	53
2015 Q1	$55.7M	Buy	952,240 +43,703	+5%	+$2.64M	0.36%	60
2014 Q4	$59.5M	Sell	908,537 -76,586	-8%	-$4.83M	0.4%	56
2014 Q3	$56.9M	Sell	985,123 -586,021	-37%	-$32.5M	0.4%	55
2014 Q2	$88.7M	Buy	1,571,144 +174,306	+12%	+$9.14M	0.62%	40
2014 Q1	$71.8M	Sell	1,396,838 -130,740	-9%	-$6.61M	0.26%	121
2013 Q4	$80.7M	Sell	1,527,578 -81,282	-5%	-$3.99M	0.31%	88
2013 Q3	$72M	Buy	1,608,860 +10,827	+0.7%	+$480K	0.28%	102
2013 Q2	$66.1M	Buy	+1,598,033	New	+$69.9M	0.29%	104

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Suntrust Banks's ABBV Position: Q3 2019 in Review

Suntrust Banks increased its AbbVie (ABBV) stake by 4% in Q3 2019, buying an estimated $2.85M and bringing the position to 1,067,953 shares worth $80.9M. The position accounts for 0.42% of the portfolio, ranked #54.

Suntrust Banks first reported a position in ABBV in Q2 2013 and has held it in 26 quarters since. The position peaked at $90.8M in Q4 2018. 2,003 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

Suntrust Banks held 1,067,953 shares of AbbVie worth $80.9M as of Q3 2019.
Suntrust Banks bought 41,544 AbbVie shares in Q3 2019, an estimated $2.85M.
AbbVie made up 0.42% of Suntrust Banks's portfolio in Q3 2019, its #54 holding.
Suntrust Banks first reported a position in AbbVie in Q2 2013 and has held it in 26 quarters since.
Suntrust Banks's AbbVie position peaked at $90.8M in Q4 2018.
2,003 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.